HEADER HYDROLASE/HYDROLASE INHIBITOR 15-MAR-09 3GMZ TITLE CRYSTAL OF HUMAN ARGINASE IN COMPLEX WITH L-ORNITHINE. RESOLUTION 1.43 TITLE 2 A. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ARGINASE-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TYPE I ARGINASE, LIVER-TYPE ARGINASE; COMPND 5 EC: 3.5.3.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ARG1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET11D KEYWDS ORNITHINE BINDING, ARGININE METABOLISM, METAL-BINDING, KEYWDS 2 PHOSPHOPROTEIN, UREA CYCLE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.DI COSTANZO,D.W.CHRISTIANSON REVDAT 4 06-SEP-23 3GMZ 1 REMARK LINK REVDAT 3 19-JUN-13 3GMZ 1 JRNL REVDAT 2 20-JUL-11 3GMZ 1 JRNL REVDAT 1 26-JAN-10 3GMZ 0 JRNL AUTH M.ILIES,L.DI COSTANZO,D.P.DOWLING,K.J.THORN,D.W.CHRISTIANSON JRNL TITL BINDING OF ALPHA,ALPHA-DISUBSTITUTED AMINO ACIDS TO ARGINASE JRNL TITL 2 SUGGESTS NEW AVENUES FOR INHIBITOR DESIGN JRNL REF J.MED.CHEM. V. 54 5432 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21728378 JRNL DOI 10.1021/JM200443B REMARK 2 REMARK 2 RESOLUTION. 1.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 111891 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : THROUGHOUT REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 5513 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4790 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 393 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.06800 REMARK 3 B22 (A**2) : -1.06800 REMARK 3 B33 (A**2) : 2.13700 REMARK 3 B12 (A**2) : -0.75000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.966 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.503 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.572 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.206 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE IS AFFECTED BY PERFECT REMARK 3 HEMIHEDRAL TWINNING. THE SUBMITTED INTENSITIES DATA ARE REMARK 3 UNTWINNED, AND HAVE BEEN USED AS SUCH DURING THE REFINEMENT. THE REMARK 3 TWINNING FACTOR IS -H,-K,L AND THE TWIN FRACTION IS = 0.5 REMARK 4 REMARK 4 3GMZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000052062. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 116771 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.430 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 35.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.64000 REMARK 200 R SYM FOR SHELL (I) : 0.64000 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 2ZAV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLINE DFMO AND L-ORNITHINE REMARK 280 COMPLEXES WITH HUMAN ARGINASE I WERE PREPARED BY SOAKING THESE REMARK 280 LIGANDS INTO PRE-FORMED CRYSTALS OF THE NATIVE ENZYME, WHICH REMARK 280 WERE PREPARED BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 21 REMARK 280 C. TYPICALLY, DROPS CONTAINING 3 UL OF PROTEIN SOLUTION [3.5 MG/ REMARK 280 ML PROTEIN, 50 MM BICINE (PH 8.5), 2 MM THYMINE, 100 UM MNCL2] REMARK 280 AND 3 UL OF PRECIPITANT SOLUTION [0.1 M BIS-TRIS (PH 6.5), 28% REMARK 280 PEG MONOMETHYL ETHER 2000] WERE EQUILIBRATED OVER A 1 ML REMARK 280 RESERVOIR OF PRECIPITANT SOLUTION. VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K, PH 7.2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -90.39200 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -45.19600 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 -78.28177 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 3 REMARK 465 LYS A 4 REMARK 465 PRO A 320 REMARK 465 PRO A 321 REMARK 465 LYS A 322 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 ALA B 3 REMARK 465 LYS B 4 REMARK 465 PRO B 320 REMARK 465 PRO B 321 REMARK 465 LYS B 322 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG B 222 O CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 17 6.48 -68.53 REMARK 500 GLU A 44 31.30 -83.73 REMARK 500 ALA A 56 152.39 -44.61 REMARK 500 ASP A 61 67.92 -154.85 REMARK 500 GLN A 65 -113.46 60.32 REMARK 500 ARG A 180 -3.05 -155.76 REMARK 500 PRO B 59 -71.48 -45.85 REMARK 500 GLN B 65 -122.56 56.80 REMARK 500 ASP B 158 99.44 -63.79 REMARK 500 ARG B 180 5.18 -157.95 REMARK 500 ASP B 181 81.14 -153.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 537 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 101 ND1 REMARK 620 2 ASP A 124 OD2 95.5 REMARK 620 3 ASP A 128 OD2 91.7 89.5 REMARK 620 4 ASP A 232 OD2 105.1 85.5 162.9 REMARK 620 5 HOH A 527 O 172.6 89.8 83.1 80.5 REMARK 620 6 HOH A 528 O 100.6 163.9 88.9 91.4 74.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 536 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 124 OD1 REMARK 620 2 HIS A 126 ND1 94.3 REMARK 620 3 ASP A 232 OD2 85.9 170.7 REMARK 620 4 ASP A 234 OD1 134.8 94.0 92.4 REMARK 620 5 ASP A 234 OD2 79.0 104.1 85.0 55.9 REMARK 620 6 HOH A 527 O 89.1 85.4 85.4 135.8 165.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B 537 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 101 ND1 REMARK 620 2 ASP B 124 OD2 95.3 REMARK 620 3 ASP B 128 OD2 89.4 91.7 REMARK 620 4 ASP B 232 OD2 101.9 87.6 168.7 REMARK 620 5 HOH B 500 O 103.5 160.6 93.3 83.8 REMARK 620 6 HOH B 501 O 174.4 86.3 85.1 83.6 75.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B 536 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 124 OD1 REMARK 620 2 HIS B 126 ND1 93.2 REMARK 620 3 ASP B 232 OD2 87.7 170.0 REMARK 620 4 ASP B 234 OD1 130.9 94.0 92.8 REMARK 620 5 ASP B 234 OD2 74.9 100.9 88.9 56.1 REMARK 620 6 HOH B 501 O 88.1 87.2 82.9 140.7 161.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 536 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 537 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ORN A 551 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN B 536 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN B 537 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ORN B 552 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ZAV RELATED DB: PDB REMARK 900 ARGINASE I (HOMO SAPIENS): NATIVE AND UNLIGANDED STRUCTURE AT 1.70 REMARK 900 A RESOLUTION REMARK 900 RELATED ID: 3GN0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH REMARK 900 DIFLUOROMETHYLORNITHINE (DFMO). RESOLUTION 1.70 A DBREF 3GMZ A 1 322 UNP P05089 ARGI1_HUMAN 1 322 DBREF 3GMZ B 1 322 UNP P05089 ARGI1_HUMAN 1 322 SEQRES 1 A 322 MET SER ALA LYS SER ARG THR ILE GLY ILE ILE GLY ALA SEQRES 2 A 322 PRO PHE SER LYS GLY GLN PRO ARG GLY GLY VAL GLU GLU SEQRES 3 A 322 GLY PRO THR VAL LEU ARG LYS ALA GLY LEU LEU GLU LYS SEQRES 4 A 322 LEU LYS GLU GLN GLU CYS ASP VAL LYS ASP TYR GLY ASP SEQRES 5 A 322 LEU PRO PHE ALA ASP ILE PRO ASN ASP SER PRO PHE GLN SEQRES 6 A 322 ILE VAL LYS ASN PRO ARG SER VAL GLY LYS ALA SER GLU SEQRES 7 A 322 GLN LEU ALA GLY LYS VAL ALA GLU VAL LYS LYS ASN GLY SEQRES 8 A 322 ARG ILE SER LEU VAL LEU GLY GLY ASP HIS SER LEU ALA SEQRES 9 A 322 ILE GLY SER ILE SER GLY HIS ALA ARG VAL HIS PRO ASP SEQRES 10 A 322 LEU GLY VAL ILE TRP VAL ASP ALA HIS THR ASP ILE ASN SEQRES 11 A 322 THR PRO LEU THR THR THR SER GLY ASN LEU HIS GLY GLN SEQRES 12 A 322 PRO VAL SER PHE LEU LEU LYS GLU LEU LYS GLY LYS ILE SEQRES 13 A 322 PRO ASP VAL PRO GLY PHE SER TRP VAL THR PRO CYS ILE SEQRES 14 A 322 SER ALA LYS ASP ILE VAL TYR ILE GLY LEU ARG ASP VAL SEQRES 15 A 322 ASP PRO GLY GLU HIS TYR ILE LEU LYS THR LEU GLY ILE SEQRES 16 A 322 LYS TYR PHE SER MET THR GLU VAL ASP ARG LEU GLY ILE SEQRES 17 A 322 GLY LYS VAL MET GLU GLU THR LEU SER TYR LEU LEU GLY SEQRES 18 A 322 ARG LYS LYS ARG PRO ILE HIS LEU SER PHE ASP VAL ASP SEQRES 19 A 322 GLY LEU ASP PRO SER PHE THR PRO ALA THR GLY THR PRO SEQRES 20 A 322 VAL VAL GLY GLY LEU THR TYR ARG GLU GLY LEU TYR ILE SEQRES 21 A 322 THR GLU GLU ILE TYR LYS THR GLY LEU LEU SER GLY LEU SEQRES 22 A 322 ASP ILE MET GLU VAL ASN PRO SER LEU GLY LYS THR PRO SEQRES 23 A 322 GLU GLU VAL THR ARG THR VAL ASN THR ALA VAL ALA ILE SEQRES 24 A 322 THR LEU ALA CYS PHE GLY LEU ALA ARG GLU GLY ASN HIS SEQRES 25 A 322 LYS PRO ILE ASP TYR LEU ASN PRO PRO LYS SEQRES 1 B 322 MET SER ALA LYS SER ARG THR ILE GLY ILE ILE GLY ALA SEQRES 2 B 322 PRO PHE SER LYS GLY GLN PRO ARG GLY GLY VAL GLU GLU SEQRES 3 B 322 GLY PRO THR VAL LEU ARG LYS ALA GLY LEU LEU GLU LYS SEQRES 4 B 322 LEU LYS GLU GLN GLU CYS ASP VAL LYS ASP TYR GLY ASP SEQRES 5 B 322 LEU PRO PHE ALA ASP ILE PRO ASN ASP SER PRO PHE GLN SEQRES 6 B 322 ILE VAL LYS ASN PRO ARG SER VAL GLY LYS ALA SER GLU SEQRES 7 B 322 GLN LEU ALA GLY LYS VAL ALA GLU VAL LYS LYS ASN GLY SEQRES 8 B 322 ARG ILE SER LEU VAL LEU GLY GLY ASP HIS SER LEU ALA SEQRES 9 B 322 ILE GLY SER ILE SER GLY HIS ALA ARG VAL HIS PRO ASP SEQRES 10 B 322 LEU GLY VAL ILE TRP VAL ASP ALA HIS THR ASP ILE ASN SEQRES 11 B 322 THR PRO LEU THR THR THR SER GLY ASN LEU HIS GLY GLN SEQRES 12 B 322 PRO VAL SER PHE LEU LEU LYS GLU LEU LYS GLY LYS ILE SEQRES 13 B 322 PRO ASP VAL PRO GLY PHE SER TRP VAL THR PRO CYS ILE SEQRES 14 B 322 SER ALA LYS ASP ILE VAL TYR ILE GLY LEU ARG ASP VAL SEQRES 15 B 322 ASP PRO GLY GLU HIS TYR ILE LEU LYS THR LEU GLY ILE SEQRES 16 B 322 LYS TYR PHE SER MET THR GLU VAL ASP ARG LEU GLY ILE SEQRES 17 B 322 GLY LYS VAL MET GLU GLU THR LEU SER TYR LEU LEU GLY SEQRES 18 B 322 ARG LYS LYS ARG PRO ILE HIS LEU SER PHE ASP VAL ASP SEQRES 19 B 322 GLY LEU ASP PRO SER PHE THR PRO ALA THR GLY THR PRO SEQRES 20 B 322 VAL VAL GLY GLY LEU THR TYR ARG GLU GLY LEU TYR ILE SEQRES 21 B 322 THR GLU GLU ILE TYR LYS THR GLY LEU LEU SER GLY LEU SEQRES 22 B 322 ASP ILE MET GLU VAL ASN PRO SER LEU GLY LYS THR PRO SEQRES 23 B 322 GLU GLU VAL THR ARG THR VAL ASN THR ALA VAL ALA ILE SEQRES 24 B 322 THR LEU ALA CYS PHE GLY LEU ALA ARG GLU GLY ASN HIS SEQRES 25 B 322 LYS PRO ILE ASP TYR LEU ASN PRO PRO LYS HET MN A 536 1 HET MN A 537 1 HET ORN A 551 9 HET MN B 536 1 HET MN B 537 1 HET ORN B 552 9 HETNAM MN MANGANESE (II) ION HETNAM ORN L-ORNITHINE FORMUL 3 MN 4(MN 2+) FORMUL 5 ORN 2(C5 H12 N2 O2) FORMUL 9 HOH *393(H2 O) HELIX 1 1 GLY A 23 GLU A 25 5 3 HELIX 2 2 GLU A 26 ALA A 34 1 9 HELIX 3 3 GLY A 35 GLU A 42 1 8 HELIX 4 4 ASN A 69 ASN A 90 1 22 HELIX 5 5 ASP A 100 SER A 102 5 3 HELIX 6 6 LEU A 103 HIS A 115 1 13 HELIX 7 7 ASN A 139 GLY A 142 5 4 HELIX 8 8 GLN A 143 LEU A 149 1 7 HELIX 9 9 LYS A 150 LYS A 153 5 4 HELIX 10 10 SER A 170 LYS A 172 5 3 HELIX 11 11 ASP A 183 GLY A 194 1 12 HELIX 12 12 SER A 199 GLY A 207 1 9 HELIX 13 13 GLY A 207 GLY A 221 1 15 HELIX 14 14 ASP A 234 LEU A 236 5 3 HELIX 15 15 THR A 253 GLY A 268 1 16 HELIX 16 16 ASN A 279 GLY A 283 5 5 HELIX 17 17 THR A 285 PHE A 304 1 20 HELIX 18 18 GLY B 23 GLU B 25 5 3 HELIX 19 19 GLU B 26 ALA B 34 1 9 HELIX 20 20 GLY B 35 GLN B 43 1 9 HELIX 21 21 ASN B 69 ASN B 90 1 22 HELIX 22 22 ASP B 100 SER B 102 5 3 HELIX 23 23 LEU B 103 HIS B 115 1 13 HELIX 24 24 ASN B 139 GLY B 142 5 4 HELIX 25 25 GLN B 143 LEU B 149 1 7 HELIX 26 26 LYS B 150 LYS B 153 5 4 HELIX 27 27 SER B 170 LYS B 172 5 3 HELIX 28 28 ASP B 183 GLY B 194 1 12 HELIX 29 29 SER B 199 GLY B 221 1 23 HELIX 30 30 ASP B 234 LEU B 236 5 3 HELIX 31 31 THR B 253 THR B 267 1 15 HELIX 32 32 ASN B 279 GLY B 283 5 5 HELIX 33 33 THR B 285 PHE B 304 1 20 SHEET 1 A 8 CYS A 45 ASP A 52 0 SHEET 2 A 8 ARG A 6 GLY A 12 1 N ILE A 8 O ASP A 46 SHEET 3 A 8 ILE A 93 LEU A 97 1 O ILE A 93 N THR A 7 SHEET 4 A 8 LEU A 270 MET A 276 1 O LEU A 273 N VAL A 96 SHEET 5 A 8 ILE A 227 ASP A 232 1 N ILE A 227 O SER A 271 SHEET 6 A 8 GLY A 119 VAL A 123 1 N GLY A 119 O HIS A 228 SHEET 7 A 8 ILE A 174 ILE A 177 1 O VAL A 175 N TRP A 122 SHEET 8 A 8 LYS A 196 PHE A 198 1 O PHE A 198 N TYR A 176 SHEET 1 B 8 CYS B 45 ASP B 52 0 SHEET 2 B 8 ARG B 6 ALA B 13 1 N ILE B 8 O ASP B 46 SHEET 3 B 8 ILE B 93 GLY B 98 1 O LEU B 95 N GLY B 9 SHEET 4 B 8 LEU B 270 MET B 276 1 O LEU B 273 N VAL B 96 SHEET 5 B 8 ILE B 227 ASP B 232 1 N ILE B 227 O SER B 271 SHEET 6 B 8 GLY B 119 VAL B 123 1 N GLY B 119 O HIS B 228 SHEET 7 B 8 ILE B 174 ILE B 177 1 O VAL B 175 N TRP B 122 SHEET 8 B 8 LYS B 196 PHE B 198 1 O PHE B 198 N TYR B 176 LINK ND1 HIS A 101 MN MN A 537 1555 1555 2.28 LINK OD1 ASP A 124 MN MN A 536 1555 1555 2.19 LINK OD2 ASP A 124 MN MN A 537 1555 1555 2.12 LINK ND1 HIS A 126 MN MN A 536 1555 1555 2.40 LINK OD2 ASP A 128 MN MN A 537 1555 1555 2.20 LINK OD2 ASP A 232 MN MN A 536 1555 1555 2.26 LINK OD2 ASP A 232 MN MN A 537 1555 1555 2.34 LINK OD1 ASP A 234 MN MN A 536 1555 1555 2.28 LINK OD2 ASP A 234 MN MN A 536 1555 1555 2.41 LINK O HOH A 527 MN MN A 536 1555 1555 2.18 LINK O HOH A 527 MN MN A 537 1555 1555 2.32 LINK O HOH A 528 MN MN A 537 1555 1555 2.52 LINK ND1 HIS B 101 MN MN B 537 1555 1555 2.23 LINK OD1 ASP B 124 MN MN B 536 1555 1555 2.28 LINK OD2 ASP B 124 MN MN B 537 1555 1555 2.24 LINK ND1 HIS B 126 MN MN B 536 1555 1555 2.35 LINK OD2 ASP B 128 MN MN B 537 1555 1555 2.22 LINK OD2 ASP B 232 MN MN B 536 1555 1555 2.42 LINK OD2 ASP B 232 MN MN B 537 1555 1555 2.29 LINK OD1 ASP B 234 MN MN B 536 1555 1555 2.16 LINK OD2 ASP B 234 MN MN B 536 1555 1555 2.49 LINK O HOH B 500 MN MN B 537 1555 1555 2.39 LINK O HOH B 501 MN MN B 536 1555 1555 2.18 LINK O HOH B 501 MN MN B 537 1555 1555 2.29 CISPEP 1 GLY A 98 GLY A 99 0 0.39 CISPEP 2 GLY B 98 GLY B 99 0 0.80 SITE 1 AC1 7 ASP A 124 HIS A 126 ASP A 232 ASP A 234 SITE 2 AC1 7 HOH A 473 HOH A 527 MN A 537 SITE 1 AC2 7 HIS A 101 ASP A 124 ASP A 128 ASP A 232 SITE 2 AC2 7 HOH A 527 HOH A 528 MN A 536 SITE 1 AC3 15 ASP A 128 ASN A 130 SER A 137 HIS A 141 SITE 2 AC3 15 GLY A 142 ASP A 183 GLU A 186 HOH A 326 SITE 3 AC3 15 HOH A 375 HOH A 472 HOH A 473 HOH A 474 SITE 4 AC3 15 HOH A 475 HOH A 527 HOH A 528 SITE 1 AC4 7 ASP B 124 HIS B 126 ASP B 232 ASP B 234 SITE 2 AC4 7 HOH B 499 HOH B 501 MN B 537 SITE 1 AC5 7 HIS B 101 ASP B 124 ASP B 128 ASP B 232 SITE 2 AC5 7 HOH B 500 HOH B 501 MN B 536 SITE 1 AC6 15 ASP B 128 ASN B 130 SER B 137 HIS B 141 SITE 2 AC6 15 GLY B 142 ASP B 183 GLU B 186 HOH B 351 SITE 3 AC6 15 HOH B 394 HOH B 433 HOH B 444 HOH B 493 SITE 4 AC6 15 HOH B 499 HOH B 500 HOH B 501 CRYST1 90.392 90.392 69.422 90.00 90.00 120.00 P 3 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011063 0.006387 0.000000 0.00000 SCALE2 0.000000 0.012774 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014405 0.00000